SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,577.58 -555.23
( -0.73%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

65,678.73 -721.11
(-1.09%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.44 -0.05
(-0.05%)

EUR-INR

109.67 -0.05
(-0.04%)

GBP-INR

127.62 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78690

INE0MRE01011

74.2682595

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFINIUM

42.75

428.38

EPS(TTM)

Face Value()

Div & Yield %

6.43

Back

Aplab reports standalone net loss of Rs 2.52 crore in the June 2026 quarter

Jul 30,2026

Net loss of Aplab reported to Rs 2.52 crore in the quarter ended June 2026 as against net profit of Rs 0.85 crore during the previous quarter ended June 2025. Sales declined 37.80% to Rs 9.61 crore in the quarter ended June 2026 as against Rs 15.45 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	9.61	15.45	-38
OPM %	-26.64	11.26	-
PBDT	-2.86	1.25	PL
PBT	-3.06	1.13	PL
NP	-2.52	0.85	PL

75,577.58 -555.23 ( -0.73%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

65,678.73 -721.11 (-1.09%)

10,817.95 -13.14 (-0.12%)

94.44 -0.05 (-0.05%)

109.67 -0.05 (-0.04%)

127.62 -0.01 (-0.01%)

0.60 0.00 (0.12%)